PROTHENA CORP PUBLIC LTD CO·4

Jan 24, 7:01 PM ET

Walker Karin L 4

4 · PROTHENA CORP PUBLIC LTD CO · Filed Jan 24, 2024

Insider Transaction Report

Form 4
Period: 2024-01-24
Walker Karin L
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares, par value $0.01 per share

    2024-01-24$13.53/sh+5,000$67,6505,000 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2024-01-24$34.00/sh5,000$170,0000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-01-245,00015,000 total
    Exercise: $13.53Exp: 2029-02-27Ordinary Shares (5,000 underlying)
Footnotes (2)
  • [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023.
  • [F2]The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 27, 2020, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary